RxDoctor Payments DataLook up a doctor →

Diana Castro

Neurology with Special Qualifications in Child Neurology · Denton, TXNPI 1750554689

Payments from drug & device makers

$2,816,366in general payments, 2019–2025

Across 450 payments — averaging $6258.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$1.4M
  • CSL Behring$495K
  • Sarepta Therapeutics, Inc.$466K
  • Genentech, Inc.$110K
  • Argenx US, Inc.$66K
  • Takeda Pharmaceuticals U.S.A., Inc.$65K
  • plus $220K from 20 others
$2,233in research payments, 2019–2025

Across 1 payment — averaging $2233.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,816,366 in reported general payments places this provider in the 95th percentile of 193 neurology with special qualifications in child neurology providers in Texas.

See all neurology with special qualifications in child neurology providers in Texas

Other neurology with special qualifications in child neurology in Denton

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →